These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21908947)

  • 1. The characteristics of food intake in patients with type II citrullinemia.
    Nakamura M; Yazaki M; Kobayashi Y; Fukushima K; Ikeda S; Kobayashi K; Saheki T; Nakaya Y
    J Nutr Sci Vitaminol (Tokyo); 2011; 57(3):239-45. PubMed ID: 21908947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: Towards prevention of adult-onset type II citrullinemia.
    Okano Y; Okamoto M; Yazaki M; Inui A; Ohura T; Murayama K; Watanabe Y; Tokuhara D; Takeshima Y
    Mol Genet Metab; 2021 May; 133(1):63-70. PubMed ID: 33741270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced carbohydrate intake in citrin-deficient subjects.
    Saheki T; Kobayashi K; Terashi M; Ohura T; Yanagawa Y; Okano Y; Hattori T; Fujimoto H; Mutoh K; Kizaki Z; Inui A
    J Inherit Metab Dis; 2008 Jun; 31(3):386-94. PubMed ID: 18415701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food Preferences of Patients with Citrin Deficiency.
    Okamoto M; Okano Y; Okano M; Yazaki M; Inui A; Ohura T; Murayama K; Watanabe Y; Tokuhara D; Takeshima Y
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2.
    Okano Y; Ohura T; Sakamoto O; Inui A
    Mol Genet Metab; 2019 Jul; 127(3):175-183. PubMed ID: 31255436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus exacerbates citrin deficiency via glucose toxicity.
    Watanabe Y; Numakura C; Tahara T; Fukui K; Torimura T; Hiromatsu Y; Tomotsune K; Yamakawa M; Hayasaka K
    Diabetes Res Clin Pract; 2020 Jun; 164():108159. PubMed ID: 32335094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical findings in five Turkish patients with citrin deficiency and identification of a novel mutation on SLC25A13.
    Köse MD; Kagnici M; Özdemir TR; Erdur CB; Erdemir G; Karakoyun M; Guzin Y; Ceylaner S; Genel F
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):157-163. PubMed ID: 31809266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency.
    Fukushima K; Yazaki M; Nakamura M; Tanaka N; Kobayashi K; Saheki T; Takei H; Ikeda S
    Intern Med; 2010; 49(3):243-7. PubMed ID: 20118603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic approaches for patients with adult-onset type II citrullinemia (CTLN2): effectiveness of treatment with low-carbohydrate diet and sodium pyruvate].
    Yazaki M; Ikeda S; Kobayashi K; Saheki T
    Rinsho Shinkeigaku; 2010 Nov; 50(11):844-7. PubMed ID: 21921468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progresses and perspectives in the study on citrin deficiency].
    Lu YB; Peng F; Li MX; Kobayashi K; Saheki T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):655-8. PubMed ID: 17160946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2).
    Yazaki M; Takei Y; Kobayashi K; Saheki T; Ikeda S
    Intern Med; 2005 Mar; 44(3):188-95. PubMed ID: 15805705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations.
    Kobayashi K; Bang Lu Y; Xian Li M; Nishi I; Hsiao KJ; Choeh K; Yang Y; Hwu WL; Reichardt JK; Palmieri F; Okano Y; Saheki T
    Mol Genet Metab; 2003 Nov; 80(3):356-9. PubMed ID: 14680984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia.
    Yasuda T; Yamaguchi N; Kobayashi K; Nishi I; Horinouchi H; Jalil MA; Li MX; Ushikai M; Iijima M; Kondo I; Saheki T
    Hum Genet; 2000 Dec; 107(6):537-45. PubMed ID: 11153906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency.
    Saheki T; Kobayashi K; Iijima M; Nishi I; Yasuda T; Yamaguchi N; Gao HZ; Jalil MA; Begum L; Li MX
    Metab Brain Dis; 2002 Dec; 17(4):335-46. PubMed ID: 12602510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD).
    Saheki T; Kobayashi K
    J Hum Genet; 2002; 47(7):333-41. PubMed ID: 12111366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia.
    Hayasaka K; Numakura C; Toyota K; Kakizaki S; Watanabe H; Haga H; Takahashi H; Takahashi Y; Kaneko M; Yamakawa M; Nunoi H; Kato T; Ueno Y; Mori M
    Mol Genet Metab Rep; 2014; 1():42-50. PubMed ID: 27896073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency.
    Lu YB; Kobayashi K; Ushikai M; Tabata A; Iijima M; Li MX; Lei L; Kawabe K; Taura S; Yang Y; Liu TT; Chiang SH; Hsiao KJ; Lau YL; Tsui LC; Lee DH; Saheki T
    J Hum Genet; 2005; 50(7):338-346. PubMed ID: 16059747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.
    Hayasaka K; Numakura C; Yamakawa M; Mitsui T; Watanabe H; Haga H; Yazaki M; Ohira H; Ochiai Y; Tahara T; Nakahara T; Yamashiki N; Nakayama T; Kon T; Mitsubuchi H; Yoshida H
    J Inherit Metab Dis; 2018 Sep; 41(5):777-784. PubMed ID: 29651749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestation and long-term outcome of citrin deficiency: Report from a nationwide study in Japan.
    Kido J; Häberle J; Sugawara K; Tanaka T; Nagao M; Sawada T; Wada Y; Numakura C; Murayama K; Watanabe Y; Kojima-Ishii K; Sasai H; Kosugiyama K; Nakamura K
    J Inherit Metab Dis; 2022 May; 45(3):431-444. PubMed ID: 35142380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle.
    Saheki T; Kobayashi K; Iijima M; Horiuchi M; Begum L; Jalil MA; Li MX; Lu YB; Ushikai M; Tabata A; Moriyama M; Hsiao KJ; Yang Y
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S20-6. PubMed ID: 15050970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.